Latest News
Biogen’s litifilimab receives FDA Breakthrough Therapy Designation to further develop treatment for cutaneous lupus erythematosus
U.S. House of Representatives Passes Legislation Totaling $27 Million in Funding for Lupus Programs
New study identifies 15 herbal supplements to potential skin flare activity in people with autoimmune skin diseases
New Phase III study results support self-administered Saphnelo as an effective treatment option for systemic lupus erythematosus
Upcoming Support Group Meetings
